<i>Clostridium difficile</i> associated infection: view of hospital-based health technology assessment by Y. M. Gomon

“…Efforts to prevent episodes of Clostridium difficile associated colitis, as well as the development of new treatment regimens are important for reducing the burden of the disease, and the resulting calculations can provide useful information when conducting pharmacoeconomical analysis of new treatment regimens for the disease.…”
Get full text

From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work by Jean-Pierre Boissel, Frédéric Cogny, Nicholas Marko, François-Henri Boissel

“…One of the consequences of this inaccuracy is that pharmacoeconomic and postmarketing surveillance studies based on direct use of clinical trial efficacy metrics are flawed. …”
Get full text

Emerging Role of Biosimilars in Oncology-Hematology in Saudi Arabia: A Practical Perspective by Mansoor A. Khan, Mohammed A. Aseeri, Majed A. Alshamrani, Abdelmajid H. Alnatsheh, Hani S. Alhamdan

“…It also described the pharmacoeconomic impact of biosimilar in oncology and formulary consideration of oncology biosimilars substituting with their originators in major oncology centers in the Saudi Arabia. …”
Get full text

ANALISIS FARMAKOEKONOMI PERESEPAN ANTIBIOTIKA CEFTRIAXONE DAN CEFTAZIDIME PADA PASIEN BEDAH SESAR DI RUMAH SAKIT PANTI RINI YOGYAKARTA by Maria Wisnu Donowati

“…Total antibiotics cost in a day by using Pharodime® is cheaper Rp. 34,663 than Tricefin®. Keywords: pharmacoeconomic, antibiotic, prescription.…”
Get full text

Experience in using povidone-iodine to treat superficial and full-thickness burns by O. V. Vladimirova, P. M. Lavreshin, V. I. Vladimirov, A. E. Rybalko, I. A. Zybinskiy

“…Choosing the most effective antiseptic agent for burn injuries is crutial both from the perspective of effective local treatment of wounds and wound complications and from the perspective of pharmacoeconomic aspects. At the current time, povidone iodine solution and ointment are one of the leading antiseptics used at all stages of care for burn patients. …”
Get full text

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) by M. A. Demidova, N. N. Kirilenko

“…Costs of pharmacotherapy and cost structure were determined. Pharmacoeconomical methods, especially ABC analysis, were partially used.  …”
Get full text

Marketing assessment of the potential of the Russian pharmaceutical market in the framework of etiotropic therapy of children with campylobacteriosis by D. D. Demchenko, K. D. Ermolenko, Yu. V. Lobzin, I. A. Narkevich, O. D. Nemyatykh, V. N. Timchenko, Yu. V. Matlashevskaya

“…Solving the problem of improving the quality of medical care for children with campylobacteriosis determines the prospects for further research based on the principles of evidence-based medicine using the tools of mathematical-statistical and pharmacoeconomic analyses.…”
Get full text

Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil by Maurílio de Souza Cazarim, Altacílio Aparecido Nunes, Leonardo Régis Leira Pereira

“…The aim of this study was to analyze the costs and outcomes of systemic arterial hypertension (SAH) for conventional assistance compared to assistance with PC in the PHS. This is a pharmacoeconomic study with cost-consequence analysis nested to clinical trial. …”
Get full text

La tromboprofilassi post-chirurgica e la terapia del tromboembolismo venoso con eparine a basso peso molecolare: ruolo della bemiparina in una strategia di minimizzazione dei costi by Lorenzo Pradelli, Mario Eandi

“…The clinical and economical consequences of the pharmacological differences between LMWHs and UFH are analyzed with a “value matrix”, a pharmacoeconomical technique for preliminary evaluations. …”
Get full text

Monte-Carlo simulation of clinical and economic effectiveness of drugs (on example of antibiotics therapy of acute bronchitis with bronchospasm in children) by Olga V. Zhukova

“…Results and discussion: Most positive clinical outcomes were observed with the use of macrolides, which also provided the lowest CER (cost-efficiency ratio), and are, therefore, optimal pharmacoeconomically. During the trial, the confidence intervals were evaluated for the clinical efficiency (95% CI of the β-distribution curve). …”
Get full text

The Economic Burden of Localized Prostate Cancer and Insights Derived from Cost-Effectiveness Studies of the Different Treatments by David Cantarero-Prieto, Javier Lera, Paloma Lanza-Leon, Marina Barreda-Gutierrez, Vicente Guillem-Porta, Luis Castelo-Branco, Jose M. Martin-Moreno

“…Future results of ongoing clinical trials that are considering genetic characteristics in assessing treatment response of patients with localized prostate cancer may shed new light on important clinical and pharmacoeconomic decisions.…”
Get full text

Storia naturale dell’infiammazione allergica by Maria Angela Tosca, Giorgio Ciprandi

“…The chronic treatment with antiallergic drugs appears to be favorable also from a pharmacoeconomical point of view, as it is associated with a reduction of overall pharmaceutical expenses and of lost working/school days, as well as determining an improved quality of life for the patient and its relatives, particularly in pediatric age. …”
Get full text

Statistical significance of polymeric physicochemical properties in the development of formulations containing a drug from neutral class by Vinod L. Gaikwad, Manish S. Bhatia, Indrajeet Singhvi

“…QSPR models were developed with enough prediction potential for the properties of formulation containing any neutral drug and could also help to decide the formulation composition for required characteristics together with pharmacoeconomic impact with respect to time, cost and material.…”
Get full text

Evidence-based therapy for knee osteoarthritis: expected short-, medium-, and long-term outcomes of prescription crystalline glucosamine sulfate administration by L. N. Denisov, L. I. Alekseeva, E. G. Zotkin, I. S. Dydykina, A. M. Lila, S. S. Rodionova, A. Yu. Kochish, E. A. Trofimov, E. Z. Yakupov, S. P. Yakupova, L. N. Eliseeva

“…These studies confirmed the favorable safety profile of pGCAS, which was comparable to placebo in the incidence of adverse events. Pharmacoeconomic studies have also demonstrated greater cost-effectiveness of pGCAS compared to other GCA drugs.A group of Russian experts at a meeting of the advisory committee reviewed the evidence in favor of the use of pGCAS and evidence of its effectiveness in the treatment of knee OA in comparison with other products that include GCA, and the fixed combination of GCA with CS. …”
Get full text

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) by M. A. Demidova, N. N. Kirilenko

“…Costs of pharmacotherapy and cost structure were determined. Pharmacoeconomical methods, especially ABC analysis, were partially used.  …”
Get full text

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events by O. V. Shatalova

“…<p><strong>Aim</strong>. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).…”
Get full text

A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid by Lutfi Al-Kathiri, Varghese Mercyamma, Tasneem Al-Najjar

“…This low-dose regimen of IVIG has a pharmacoeconomic benefit compared with the previous cumulative dose (3 g/kg), which is usually given by dermatologists in other institutions to patients with TEN. …”
Get full text

Value-based procurement of prostheses for total knee replacement by Andrea Messori, Sabrina Trippoli

“…This study explored how pharmacoeconomic models can inform the procurement of TKA devices to improve their value for money. …”
Get full text

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II by Ruth Kent, Adrian Robertson, Sandra Quiñones Aguilar, Charalampos Tzoulis, John Maltman

“…These real-world utilization data may have pharmacoeconomic implications.…”
Get full text

Farmaci antipertensivi a confronto: costi e benefici per il paziente e la collettività by Francesco Vittorio Costa

“…Pharmacoeconomic analysis of antihypertensive treatment should be performed following a correct methodological evaluation and considering with accuracy both costs and benefits of different therapeutic options. …”
Get full text